The data requested is not currently held by the department and to provide it would incur disproportionate cost.

We are unable to provide a response to this request as it is not possible for us to identify the data requested by geographic location.

We are unable to provide a response to this request as it is not possible for us to identify the data requested by geographic location.

UK Visas and Immigration are currently operating within their global customer service standards across all of the main legal migration routes for customers who make an entry clearance application from overseas and for applications made inside the UK.

Details of current performance against these customer service standards are updated regularly and can be found at:

Visa decision waiting times: applications outside the UK - GOV.UK (www.gov.uk)(opens in a new tab).

Visa decision waiting times: applications inside the UK - GOV.UK (www.gov.uk).

The information requested could not be obtained without disproportionate cost.

The data requested is not available in a reportable format.

The right to stay indefinitely is one of the most valuable entitlements offered for those seeking to enter or remain in the UK, and it is right that the fee should be higher than most for migrants staying temporarily in the UK.

A grant of indefinite leave to remain is not necessary to enable people to remain in the UK on the basis of their Article 8 or other ECHR rights, as these can be met through a grant of limited leave to remain. The provision of an affordability-based waiver for limited leave on family and private life routes allows an individual or family to remain here lawfully, and to then apply for settlement and pay the fee when the funds become available. As such, there are no plans to waive the fee for indefinite leave to remain.

We do not currently hold any information regarding the proportion of these people who might have limited leave to remain in the UK and are consequently awaiting a decision on a visa extension application are on the ten-year route to settlement.

Those who meet all eligibility and specified evidential requirements of the Family Immigration Rules, will be granted on a five-year route to settlement (granted in two periods of 30 months, with a third application for indefinite leave to remain). Those who cannot or do not meet these requirements, or seek to rely on their private life, will instead have a longer route to settlement: 10 years (granted in four periods of 30 months, with a fifth application for indefinite leave to remain). This reflects our obligations under Article 8 of the ECHR.

The 10 year route, provides additional time for those applicants to better integrate into British society by being able to achieve an appropriate knowledge of the English language which, in turn, will enable them to obtain employment and take a full and active part in their community.

We are in the process of simplifying the immigration system, including the ten-year routes to settlement. As part of this simplification the impact of existing policies will be taken into account

The Department does not directly decide the locations from which specialised services are provided on the National Health Service. NHS England is responsible for commissioning services which are prescribed as specialised services in legislation to meet the health needs of people across England. Other medical services are commissioned by one of 42 integrated care boards, or if relevant, by local authorities, for their relevant populations across England.

Defra is conducting analysis of its Retained EU Law stock to determine what should be preserved as part of domestic law, as well as REUL that should be removed, or amended. A list of regulations to be revoked or allowed to sunset, through the REUL Bill will be published in due course.

This Government are committed to delivering high-quality public services. For instance, by next month, there will be a record number of police officers serving communities across Wales, and we have seen crime decrease by 10% across England and Wales between 2021 and 2022. As the hon. Lady is aware, many public services, including health and education, are devolved in Wales.

As set out in the Autumn Statement, the Government will develop a new approach to consumer protection in energy markets, which will apply from April 2024 onwards.

The Government is committed to work with consumer groups and industry to consider the best approach, including options such as social tariffs, as part of wider retail market reforms.

The requirements for the information which must appear on medicines labelling is set out in Part 13 of the Human Medicines Regulations 2012. The primary purpose of the label is to unambiguously identify the medicine and to convey warnings in relation to safe and effective use of the product. There is no legal requirement for a pharmaceutical manufacturer to state whether a particular medicine contains animal-derived ingredients, as this does not convey warnings on the safety of the medicine.

However, the legislation allows for the inclusion of a statement such as ‘suitable for vegetarians/vegans’ where a company can provide evidence to demonstrate that no products of animal origin have been used in the manufacture of the ingredients or the medicine. Where a company proposes to include such a statement on the labelling or in the patient information leaflet, the Medicines and Healthcare products regulatory Agency will evaluate the evidence to determine the validity. Medicines are developed to treat or prevent particular medical conditions or symptoms and are licensed on the basis of quality, safety and efficacy. Although there are many medicines free from animal derived materials, no animal-free treatment options exist as the active ingredient cannot be made synthetically or animal derived materials are necessary for the formulation or manufacture of the product. As technology advances, we expect that more non-animal materials will become available.

The requirements for the information which must appear on medicines labelling is set out in Part 13 of the Human Medicines Regulations 2012. The primary purpose of the label is to unambiguously identify the medicine and to convey warnings in relation to safe and effective use of the product. There is no legal requirement for a pharmaceutical manufacturer to state whether a particular medicine contains animal-derived ingredients, as this does not convey warnings on the safety of the medicine.

However, the legislation allows for the inclusion of a statement such as ‘suitable for vegetarians/vegans’ where a company can provide evidence to demonstrate that no products of animal origin have been used in the manufacture of the ingredients or the medicine. Where a company proposes to include such a statement on the labelling or in the patient information leaflet, the Medicines and Healthcare products regulatory Agency will evaluate the evidence to determine the validity. Medicines are developed to treat or prevent particular medical conditions or symptoms and are licensed on the basis of quality, safety and efficacy. Although there are many medicines free from animal derived materials, no animal-free treatment options exist as the active ingredient cannot be made synthetically or animal derived materials are necessary for the formulation or manufacture of the product. As technology advances, we expect that more non-animal materials will become available.

I refer the Hon and Rt Hon Members to the answer I gave on 13 December 2022 to Question UIN 106507.

The FCDO has regularly lobbied the Government of India (GoI) to improve visa services for British Citizens and will continue to update Travel Advice on GOV.UK with the latest information. Most recently, the Foreign Secretary raised the lack of e-visas for British Citizens with the Indian External Affairs Minister during his visit to India on 29 October. Lord (Tariq) Ahmad of Wimbledon also raised it with the Indian High Commissioner on 25 October. We will continue to press India to re-introduce e-visas for British Citizens.

Smart meters use radio waves in the home to allow remote readings to be taken from gas and electricity meters. There is no evidence that radio waves produced by smart meters pose a health risk. More information can be found here: https://www.gov.uk/government/publications/smart-meters-radio-waves-and-health/smart-meters-radio-waves-and-health.

In respect of 5G, UK Health Security Agency (UKHSA) advice states that there should be no consequences for public health. More information can be found here: https://www.gov.uk/government/publications/5g-technologies-radio-waves-and-health/5g-technologies-radio-waves-and-health.

Smart meters use radio waves in the home to allow remote readings to be taken from gas and electricity meters. There is no evidence that radio waves produced by smart meters pose a health risk. More information can be found here: https://www.gov.uk/government/publications/smart-meters-radio-waves-and-health/smart-meters-radio-waves-and-health.

In respect of 5G, UK Health Security Agency (UKHSA) advice states that there should be no consequences for public health. More information can be found here: https://www.gov.uk/government/publications/5g-technologies-radio-waves-and-health/5g-technologies-radio-waves-and-health.